Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz
- 18 January 2002
- journal article
- Published by Wiley
- Vol. 53 (2) , 212-214
- https://doi.org/10.1046/j.0306-5251.2001.01539.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.2001
- Methadone Maintenance Treatment: Is It Possible to Adapt the Daily Doses to the Metabolic Activity of the Patient?Therapeutic Drug Monitoring, 2001
- Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitorEuropean Journal of Clinical Pharmacology, 2001
- Steady‐state pharmacokinetics of (R)‐ and (S)‐methadone in methadone maintenance patientsBritish Journal of Clinical Pharmacology, 2000
- Alpha1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndromeInt. Journal of Clinical Pharmacology and Therapeutics, 2000
- The roles of P‐glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sacFundamental & Clinical Pharmacology, 1999
- Population pharmacokinetics of methadone in opiate users: characterization of time‐dependent changesBritish Journal of Clinical Pharmacology, 1999
- The pharmacokinetics of methadone in healthy subjects and opiate usersBritish Journal of Clinical Pharmacology, 1997
- Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)1993
- Pharmacokinetics of methadone in methadone maintenance treatment: Characterization of therapeutic failuresEuropean Journal of Clinical Pharmacology, 1983